Heartbeam Price Target Maintained With a $8.00/Share by Benchmark
Heartbeam Price Target Maintained With a $8.00/Share by Benchmark
Express News | Benchmark Reiterates Speculative Buy on HeartBeam, Maintains $8 Price Target
HeartBeam Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/25/2024 279.15% Benchmark → $8 Reiterates Speculative Buy → Speculative Buy 11/16/2023 279.15% Benchmar
NVFY, BEAT and NTRB Are Among Pre Market Gainers
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2023 Earnings Call Transcript
Q4 2023 Heartbeam Inc Earnings Call
Earnings Call Summary | HeartBeam(BEAT.US) Q4 2023 Earnings Conference
The following is a summary of the HeartBeam, Inc. (BEAT) Q4 2023 Earnings Call Transcript:Financial Performance:HeartBeam ended 2023 with cash and cash equivalents totaling $16.2 million, allowing ope
Recap: HeartBeam Q4 Earnings
HeartBeam (NASDAQ:BEAT) reported its Q4 earnings results on Wednesday, March 20, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsHeartBeam missed estimated earnings
Express News | HeartBeam Q4 2023 GAAP EPS $(0.13), Inline
Heartbeam 4Q Loss/Shr 72c >BEAT
Heartbeam 4Q Loss/Shr 72c >BEAT
Press Release: HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results -- First Patients Enrolled in Pivotal Study Evaluating AIMIGo(TM) System for Synthesizing a 12-Lead ECG -- Ongoing
A Preview Of HeartBeam's Earnings
HeartBeam (NASDAQ:BEAT) is set to give its latest quarterly earnings report on Wednesday, 2024-03-20. Here's what investors need to know before the announcement.Analysts estimate that HeartBeam will r
Express News | HeartBeam Announces First Patients Enrolled In Study Evaluating AIMIGo System For Synthesizing A 12-Lead ECG
What's Going On With Heartbeam (BEAT) Stock?
Heartbeam Inc (NASDAQ:BEAT) shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2.70. The earlier move higher came despite a lack of company-specific news f
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersPsyence Biomedical (NASDAQ:PBM) stock moved upwards by 35.3% to $1.38 during Thursday's regular session. The market value of their outstanding shares is at $18.4 million. ZyVersa Therapeutics (
Express News | HeartBeam Receives Two New US Patents For Its Core Cardiac Monitoring Technology
HeartBeam Receives Two New US Patents for Its Core Cardiac Monitoring Technology
Company Continues Expanding its Intellectual Property Footprint, Now has 14 US and 4 International Patents HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care through the
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersSCWorx (NASDAQ:WORX) stock increased by 60.8% to $2.75 during Wednesday's after-market session. The market value of their outstanding shares is at $3.3 million. IO Biotech (NASDAQ:IOBT) stock i
Press Release: HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 P.m. Eastern Time
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time SANTA CLARA, Calif.--(BUSINESS WIRE)--March 05, 2024-- HeartBeam, In
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersJanux Therapeutics (NASDAQ:JANX) stock rose 120.5% to $33.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.5 billion. Viking Therapeutics (NASDAQ:VKT
No Data